Storia in 3 fonti

Qureight raises $20m for a chest AI to speed drug trials

Cambridge’s Qureight raised a $20m Series B to build an AI “foundation model” of the chest, to speed up lung and heart drug trials.

Raccontata da

techfundingnews.com

tech.eu

thenextweb.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

thenextweb.comStai leggendo6 g fa

Qureight raises $20m for a chest AI to speed drug trials

Qureight raised $20m for a 3D chest model generating disease variants in 1-2 months vs. a year, cutting trial imaging from 2 weeks to 48 hours. Foundation models in pharma—reusable over custom builds—accelerate trial cycles and reduce biotech development risk.

originale

techfundingnews.com6 g fa

Exclusive: Cambridge's Qureight raises $20M to bring AI to lung and heart clinical trials — TFN

Qureight raised $20M Series B for AI imaging in clinical trials, cutting turnaround from two weeks to 48 hours. Automating imaging analysis cuts pharma's R&D bottleneck, compressing drug development cycles and accelerating time-to-market for new therapeutics.

Qureight raises $20m for a chest AI to speed drug trials

Confronto fonti

Qureight raises $20m for a chest AI to speed drug trials

Exclusive: Cambridge's Qureight raises $20M to bring AI to lung and heart clinical trials — TFN

Timeline cronologica

Exclusive: Cambridge's Qureight raises $20M to bring AI to lung and heart clinical trials — TFN

Qureight secures $20M Series B to expand AI-powered imaging platform for clinical trials

Qureight secures $20M Series B to expand AI-powered imaging platform for clinical trials

Qureight raises $20m for a chest AI to speed drug trials